HK1065334A1 - Polynucleotide useful for modulating cancer cell proliferation - Google Patents

Polynucleotide useful for modulating cancer cell proliferation

Info

Publication number
HK1065334A1
HK1065334A1 HK04108190A HK04108190A HK1065334A1 HK 1065334 A1 HK1065334 A1 HK 1065334A1 HK 04108190 A HK04108190 A HK 04108190A HK 04108190 A HK04108190 A HK 04108190A HK 1065334 A1 HK1065334 A1 HK 1065334A1
Authority
HK
Hong Kong
Prior art keywords
cell proliferation
cancer cell
modulating cancer
polynucleotide useful
modulating
Prior art date
Application number
HK04108190A
Other languages
English (en)
Inventor
Eric Ferrandis
Jose-Antonio Camara Y Ferrer
Jean Martinez
Christophe Thurieau
Original Assignee
Sod Conseils Rech Applic
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Centre Nat Rech Scient filed Critical Sod Conseils Rech Applic
Publication of HK1065334A1 publication Critical patent/HK1065334A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK04108190A 2001-03-01 2004-10-20 Polynucleotide useful for modulating cancer cell proliferation HK1065334A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0102801A FR2821624B1 (fr) 2001-03-01 2001-03-01 Nouveau polynucleotide utilisable pour moduler la proliferation des cellules cancereuses
PCT/FR2002/000740 WO2002070700A1 (fr) 2001-03-01 2002-03-01 Polynucleotide utilisable pour moduler la proliferation des cellules cancereuses

Publications (1)

Publication Number Publication Date
HK1065334A1 true HK1065334A1 (en) 2005-02-18

Family

ID=8860611

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04108190A HK1065334A1 (en) 2001-03-01 2004-10-20 Polynucleotide useful for modulating cancer cell proliferation

Country Status (21)

Country Link
US (1) US7214533B2 (de)
EP (1) EP1368474B1 (de)
JP (1) JP4190291B2 (de)
KR (1) KR100869190B1 (de)
CN (1) CN1289670C (de)
AT (1) ATE351906T1 (de)
AU (1) AU2002335492B2 (de)
BR (1) BR0207253A (de)
CA (1) CA2437535C (de)
CZ (1) CZ20032670A3 (de)
DE (1) DE60217651T2 (de)
ES (1) ES2279877T3 (de)
FR (1) FR2821624B1 (de)
HK (1) HK1065334A1 (de)
HU (1) HUP0303312A3 (de)
IL (1) IL157091A0 (de)
MX (1) MXPA03007694A (de)
NZ (1) NZ527261A (de)
PL (1) PL204844B1 (de)
RU (1) RU2307666C2 (de)
WO (1) WO2002070700A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2430194A4 (de) 2009-05-11 2013-09-04 Berg Pharma Llc Verfahren zur diagnose von onkologischen erkrankungen mit epimetabolischen shiftern, mehrdimensionalen intrazellularen molekülen oder umgebungsbeeinflussern
KR101933732B1 (ko) 2011-04-04 2018-12-28 버그 엘엘씨 중추 신경 시스템 종양들의 치료 방법
AU2014251045B2 (en) 2013-04-08 2019-06-13 Berg Llc Treatment of cancer using coenzyme Q10 combination therapies
HUE050060T2 (hu) 2013-09-04 2020-11-30 Berg Llc Eljárások rák kezelésére koenzim Q10 folyamatos infúziójával
CA2975583A1 (en) * 2014-11-14 2016-05-19 Voyager Therapeutics, Inc. Modulatory polynucleotides
EP3458588A4 (de) 2016-05-18 2020-01-15 Voyager Therapeutics, Inc. Modulatorische polynukleotide
IL297576B2 (en) * 2016-05-18 2024-02-01 Voyager Therapeutics Inc Preparations and methods for treating Huntington's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637456A (en) * 1995-02-17 1997-06-10 The University Of Texas, Board Of Regents Rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation
WO2000069454A1 (en) * 1999-05-17 2000-11-23 Board Of Regents, The University Of Texas System Suppression of endogenous igfbp-2 to inhibit cancer

Also Published As

Publication number Publication date
IL157091A0 (en) 2004-02-08
KR100869190B1 (ko) 2008-11-18
DE60217651D1 (de) 2007-03-08
KR20030090655A (ko) 2003-11-28
MXPA03007694A (es) 2004-03-16
BR0207253A (pt) 2004-02-10
HUP0303312A2 (hu) 2003-12-29
US20040197783A1 (en) 2004-10-07
CZ20032670A3 (cs) 2004-04-14
WO2002070700A1 (fr) 2002-09-12
EP1368474B1 (de) 2007-01-17
HUP0303312A3 (en) 2012-09-28
RU2003129163A (ru) 2005-02-20
NZ527261A (en) 2005-06-24
ES2279877T3 (es) 2007-09-01
JP2004527240A (ja) 2004-09-09
CA2437535C (fr) 2011-05-10
EP1368474A1 (de) 2003-12-10
CN1289670C (zh) 2006-12-13
AU2002335492B2 (en) 2006-11-02
FR2821624A1 (fr) 2002-09-06
CN1494591A (zh) 2004-05-05
JP4190291B2 (ja) 2008-12-03
ATE351906T1 (de) 2007-02-15
DE60217651T2 (de) 2007-10-18
PL365226A1 (en) 2004-12-27
CA2437535A1 (fr) 2002-09-12
US7214533B2 (en) 2007-05-08
RU2307666C2 (ru) 2007-10-10
FR2821624B1 (fr) 2004-01-02
PL204844B1 (pl) 2010-02-26

Similar Documents

Publication Publication Date Title
HK1095749A1 (en) Novel use of peptide compounds for in production of pharmacenticals for treating central neuropathic pain
AU2003278725A1 (en) Polynucleotide predictor set for identifying protein tyrosine kinase modulators
DE60207759D1 (de) Pyrimidotriazine als phosphataseinhibitoren
GB2378948B (en) Novel compounds for modulating cell proliferation
IL157091A0 (en) Polynucleotide useful for modulating cancer cell proliferation
HK1052026A1 (en) Human enzymes of the metalloprotease family
GB9820003D0 (en) Novel compounds
AU2002335492A1 (en) Polynucleotide useful for modulating cancer cell proliferation
GB9809683D0 (en) Novel compounds
GB9810285D0 (en) Novel compounds
GB9812163D0 (en) Novel compounds
ATE342975T1 (de) Apoptosis induzierender faktor
GB0016362D0 (en) Tetraspanin modulation
IL149045A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
AU3667397A (en) Recombinant n-proteinase, and the production, methods and uses thereof
AU4567300A (en) Novel compounds
GB9918208D0 (en) Novel compounds
MY142798A (en) Methods for preventing glyconoylation of proteins
AU2003249999A8 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
GB9918302D0 (en) Novel compounds
GB9918003D0 (en) Novel compounds
GB0025169D0 (en) Novel compounds
GB9918206D0 (en) Novel compounds
GB9914945D0 (en) Novel compounds
GB9918281D0 (en) Novel compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120301